Ref: PXL/H.O./CIR-022/2014-15 Date: 14.07.2014
Review of some SIONS by DGFT
Dear Sir/Madam,
Sub: Review of SIONS - production and consumption data to be submitted to DGFT before 31.07.2014
We understand from the Public Notice of DGFT that the following SIONS pertaining to Chemical and Allied Products are being reviewed:
Sl. No.
|
SION No.
|
Product name
|
1
|
A-197
|
DL Naproxen
|
2
|
A -311
|
Naproxen Sodium
|
3
|
A -312
|
Naproxen Sodium (from N-Methyl Glucamine Route)
|
4
|
A -313
|
Naproxen Sodium (from Tartaric Acid Route)
|
5
|
A-321
|
Omeprazole
|
6
|
A-322
|
Omeprazole Pellets 8.5%
|
7
|
A-323
|
Omeprazole Pellets 8.5%
|
8
|
A-2407
|
2-(Hydroxy Methyl) 3,5, Dimethyl-4- Methoxy Pyridine (Omeprazole Intermediate)
|
9
|
A-2684
|
2-Chloromethyl-3, 5-Dimethyl-4-Methoxy Pyridine Hydrochloride
|
10
|
A-2797
|
Atorvastatin Calcium
|
11
|
A -2943
|
Naproxen
|
12
|
A -2944
|
Naproxen (from N-Methyl Glucamine Route)
|
13
|
A -2945
|
Naproxen (from Tartaric Acid Route)
|
14
|
A -2984
|
2-Acetyl 6-Methoxy Naphthalene
|
It is understood from the notification that manufacturers of above products are required to submit necessary production and consumption data in ANF 4B for such revision by 31.07.2014. Non-compliance in providing the data to them would result in stoppage of the benefit of Advance Authorization/DFIA for exports. We enclose herewith copy of the Notification for immediate reference of members.
We, therefore, advise the manufacturers of above products to take immediate note of the notification and submit the data as required by DGFT. A copy of the reply may be sent to Pharmexcil at info@pharmexcil.comto enable us recommend the SION norms requested by the members.
With regards
Dr. P V Appaji
Director General
Encl:
DGFT NOTIFICATION
|